Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
Thanks for your interest in this podcast. Please read this important program…
Thanks for your interest in this podcast. Please read this important program…
The 2nd International Glaucoma Symposium underscores how AI and advanced imaging are…
(Image Credit: AdobeStock/littlewolf1989) A press release from Mass General Brigham, Boston, reported…
(Image Credit: AdobeStock/Sangiao_Photography) Pterygium is a common ocular surface disorder characterized by…
(Image Credit: AdobeStock/SnapVault) Argenx SE has discontinued the phase 3 UplighTED studies…
(Image Credit: AdobeStock/9dreamstudio) Aviceda Therapeutics has released topline results from its phase…
The Viewpoints series “Reimagining Dry Eye Management: Targeting Tear Function for Sustained…
The Viewpoints series “Reimagining Dry Eye Management: Targeting Tear Function for Sustained…
(Image Credit: AdobeStock) Inflammasome Therapeutics has completed enrollment in a multicenter phase…
The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ cyclosporine…
Presbyopia-correcting IOLs have undergone a dramatic transformation in recent years. The once-limited…
(Image Credit: AdobeStock/platinumArt) Health Canada has approved Celltrion’s Eydenzelt, a biosimilar referencing…
Enter your email address below and subscribe to our newsletter